Toward Health Equity Oncology Grant

Due to social, environmental, and economic disparities, historically neglected and underrepresented communities are at increased risk of developing or dying from cancer. Gilead’s Toward Health Equity Oncology Grant™ (THE Oncology Grant) was established to advance health equity for people impacted by cancer, with new funding announced annually on World Cancer Day. In 2024, Gilead announced the commitment of $5 million in grant funding to support additional health equity programs globally.

In the U.S., Gilead is awarding a total of $3 million to two coalitions, made up of seven community partners, working to increase clinical trial access and participation in communities of color. Historically, there has been an absence of adequate representation in and access to oncology clinical trials from underserved and disinvested communities in the U.S. This gap leads to the generation of inapplicable data and hinders equitable access to treatment. To address these issues, there is a necessity for community-based approaches that utilize population-specific strategies, aiming to enhance access and representation in clinical trials. The U.S. THE Oncology Grant awardees are coalitions composed of organizations that are intentionally inclusive. These locally focused groups will provide services that are designed to address and overcome challenges with innovative practices and a plan for sustainability.

“This funding from Gilead supports our efforts to advance health equity in oncology and enables AHS to offer participation in cancer clinical trials, deepen learnings from these trials, improve outcomes, and advance our mission of Caring, Healing, Teaching and Serving all.” - James Jackson, Chief Executive Officer, Alameda Health System (AHS).

In Australia, Canada and Europe, Gilead is providing a total of $2 million to 29 grassroots organizations that support people impacted by metastatic breast cancer (mBC). The diagnosis rates of mBC globally underscore the ongoing challenges in early detection and effective management of this advanced stage of breast cancer. While the global incidence of mBC varies across regions, the same factors – access to screening, economic disparities, support resources – impact the care and outcomes for mBC patients.

The grants in Australia, Canada and Europe fund projects based on three pillars:

  • Person-centered care to improve health literacy and shared decision-making, and to provide community-based social support.
  • Organizational capacity-building to help improve disease awareness and the ability of impacted communities to provide critical support.
  • Supporting caregivers to improve their ability to support people living with mBC.

To date, Gilead has awarded more than $18 million in health equity-related oncology grants for programs that advance health equity for disinvested communities, including Black, Hispanic, Jewish, Native American and LGBTQ+.

2024 THE Oncology Grant Recipients

  • United States

  • Alameda Health System in collaboration with UCSF Helen Diller Family Comprehensive Cancer Center and Umoja Health

  • Georgetown University in collaboration with Nueva Vida, The African Women's Cancer Awareness Association and The Center For Black Equity 

  • Australia, Canada, Europe

  • Alliance of Women with Breast Cancer (Czech Republic)

  • Breast Cancer Now (United Kingdom)

  • Chaim Shiba Medical Center (Israel)

  • Czech Medical Society (Czech Republic)

  • Dialog Jessenius ops (Czech Republic)

  • Europa Donna Schweiz (Switzerland)

  • Evita Cancro (Portugal)

  • Family Audiobook GmbH (Germany)

  • Halsartan Foundation (Israel)

  • Helgahilft (Austria)

  • Incontra Donna (Italy)

  • InfluCancer (Austria)

  • Look Good Feel Better (Switzerland)

  • Maggie’s Cancer Centre (United Kingdom)

  • Make 2nds Count (United Kingdom)

  • Mamazone (Germany)

  • One in Nine (Israel)

  • Pink Hope (Australia)

  • Pink Ribbon (Belgium)

  • Quebec Cancer Foundation (Canada)

  • Rethink Breast Cancer (Canada)

  • Rexrodt von Firck's Foundation (Germany)

  • Semmelweis Foundation (Austria)

  • Sharing and Care Association (Portugal)

  • Stop Cancer Portugal (Portugal)

  • The Busse Collective (Germany)

  • The Garvan Institute of Medical Research (Australia)

  • The Olive Branch of Hope (Canada)

  • Zurich Cancer League (Switzerland)

Lea en Español

Read more about the 2023 THE Oncology Grant awardees here.